Heart disease congenital

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
R Respiratory (ATC R) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Oslo University Hospital HF Academic
    THEOPHYLLINE
    2022-500301-41-00 1 country 2023 n=10
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Oslo University Hospital HF Academic 1 Phase II 0
New trials by year
2023
1
← All indication landscapes